Details of issuance or disposal
Exercise status report for the 14th Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause)
3,435,000 new shares (exercised on 24 March 2026)
Exercise ratio subject to the exercise restriction: 9.99% (3,435,000 shares / 34,350,389 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 14th Series of Stock Acquisition Rights through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 3,435,000 new shares (exercised on 24 March 2026) |
| Issue price and disposal price | Exercise price: ¥38.0 |
| Intended allottee | Nagasawa Makoto (長澤誠) and EVO FUND (monthly exercise status report for previously issued stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 9.99% (3,435,000 shares / 34,350,389 shares) |
| Total number of issued shares | 102,959,569 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥38.0. The stock acquisition rights have an exercise price adjustment clause, but the floor for the adjustment is not stated in the main text. |
| Number of Stock Acquisition Rights | Total issued: 187,000; unexercised as of the end of the month preceding the relevant month: 136,200; unexercised as of the end of the relevant month: 101,850 |
| Most recent equity financing | Timing 15 December 2023 / Type Issuance of the 14th Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 14th Series of Stock Acquisition Rights in March 2026.